FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to an anti-TROP2 antibody containing its conjugate, as well as to a method for production thereof. Also disclosed is a polynucleotide encoding an anti-TROP2 antibody, as well as a vector and a cell containing it.
EFFECT: invention is effective as an anticancer agent.
14 cl, 27 dwg, 2 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TROP2 ANTIBODY-DRUG CONJUGATE | 2014 |
|
RU2743077C2 |
| ANTIBODY-DRUG CONJUGATE | 2013 |
|
RU2776489C2 |
| ANTI-HER3 CONJUGATE ANTIBODY-DRUG | 2015 |
|
RU2802211C2 |
| ANTI-CDH6-ANTIBODY AND ANTI-CDH6-ANTIBODY-DRUG CONJUGATE | 2018 |
|
RU2798285C2 |
| ANTI-MUC1 DRUG CONJUGATE | 2019 |
|
RU2804703C2 |
| ANTIBODY AGAINST GPR20 AND ANTIBODY AGAINST GPR20-DRUG CONJUGATES | 2018 |
|
RU2772804C2 |
| ANTIBODY-DRUG CONJUGATE CONTAINING NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE | 2021 |
|
RU2836814C1 |
| CONJUGATE ANTIBODY-DERIVATIVE OF PYRROLOBENZODIAZEPINE | 2018 |
|
RU2820928C2 |
| ANTIBODY-DRUG CONJUGATE TARGETING TROP2, AND METHOD FOR PREPARING AND USING SAME | 2020 |
|
RU2822663C1 |
| ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
